Literature DB >> 19630777

Opportunities and limitations of mouse models humanized for HLA class II antigens.

B M Reipert1, K N Steinitz, P M van Helden, S Unterthurner, M Schuster, R U Ahmad, J Ilas, H P Schwarz.   

Abstract

MHC class II molecules are essential for shaping the CD4+ T-cell repertoire in the thymus and for selecting antigenic peptides that are presented to CD4+ T cells in the periphery. A range of different mouse models humanized for HLA class II antigens have been developed to study the regulation of MHC-class II restricted immune responses. These mouse models have been used to identify immunodominant peptides that trigger diseases and to characterize the interactions of T-cell receptors with disease-associated peptides and MHC class II molecules. Peptides presented to CD4+ T cells in these mouse models were shown to be similar to peptides presented to CD4+ T cells in patients who carry the same MHC class II haplotype. Opportunities and limitations associated with these mouse models will be discussed and the potential application of these models for understanding the regulation of antibody responses against factor VIII in hemophilia A will be indicated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630777     DOI: 10.1111/j.1538-7836.2009.03403.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  4 in total

1.  CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.

Authors:  Katharina N Steinitz; Pauline M van Helden; Brigitte Binder; David C Wraith; Sabine Unterthurner; Corinna Hermann; Maria Schuster; Rafi U Ahmad; Markus Weiller; Christian Lubich; Maurus de la Rosa; Hans Peter Schwarz; Birgit M Reipert
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

Review 2.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 3.  Progress toward inducing immunologic tolerance to factor VIII.

Authors:  David W Scott; Kathleen P Pratt; Carol H Miao
Journal:  Blood       Date:  2013-03-15       Impact factor: 22.113

Review 4.  Current animal models of hemophilia: the state of the art.

Authors:  Ching-Tzu Yen; Meng-Ni Fan; Yung-Li Yang; Sheng-Chieh Chou; I-Shing Yu; Shu-Wha Lin
Journal:  Thromb J       Date:  2016-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.